We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WASH:NASDAQWashington Trust Bancorp, Inc. Analysis

Data as of 2026-07-30 - not real-time

$39.23

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Washington Trust Bancorp (WASH) is trading at $39.23, comfortably above its 20‑day (≈$36.99) and 50‑day (≈$35.18) SMAs and just shy of the calculated resistance of $39.85, signaling a strong short‑term bullish bias. The RSI of 63.9 and a bullish MACD histogram (+0.19) reinforce momentum, while volume is on an increasing trend, suggesting continued buying pressure. The latest Q2 2026 results showed revenue up 11% YoY to $60.47 M and GAAP EPS of $0.83, beating consensus by 7.9%, providing fresh earnings tailwinds. The bank’s profitability remains robust with a 25% profit margin and operating margin above 36%, and its forward PE of 11.1 is well below the industry average of 17.9, indicating relative cheapness. A dividend yield of 5.66% and a payout ratio near 78% make the stock attractive for income seekers, though the high payout warrants monitoring. However, a 30‑day volatility of 33.5% and a max drawdown of –18.4% highlight notable price swings, while a beta of 0.78 suggests moderate market sensitivity. Analyst consensus is neutral (hold) with a median target of $37, implying a modest downside of about 3% from current levels. Overall, the blend of solid earnings, attractive valuation metrics, and a high dividend is offset by elevated volatility and sector‑specific credit and regulatory concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and revenue growth
  • Proximity to technical resistance at $39.85
  • High dividend yield supporting demand

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Undervalued PE relative to industry peers
  • Sustained operating margins above 35%
  • Moderate beta and improving cash position

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive dividend yield with reasonable payout ratio
  • Blend of growth (10% revenue rise) and value (low forward PE)
  • Strong balance sheet fundamentals despite sector risk

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin25.07%
P/E Ratio13.6
ROE10.25%
ROA0.83%
P/B Ratio1.4
Industry P/E17.9

Technical Analysis

TrendBullish
RSI64.0
Support$34.69
Resistance$39.85
MA 20$36.99
MA 50$35.18
MA 200$32.22
MACDBullish
VolumeIncreasing
Fear & Greed Index84.54

Valuation

Target Price$38.00
Upside/Downside-3.14%
GradeFair
TypeBlend
Dividend Yield5.66%

Risk Assessment

Beta0.78
Volatility33.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.